Education, Innovation and Regenerative Medicine:
RegenLab Welcomes OSP (Office d’orientation scolaire, professionnelle et de carrière) & SHE (Service des hautes écoles ) Delegation to BioArk Tech Park
Strengthening connections between education, innovation and regenerative medicine at BioArk Tech Park Monthey
On June 16, BioArk Tech Park in Monthey welcomed approximately 120 representatives from the Office d’orientation scolaire, professionnelle et de carrière (OSP) and the Service des hautes écoles (SHE) of the Canton of Valais for an afternoon dedicated to innovation, education and Life Sciences.
The event brought together key stakeholders from academia, industry and professional training institutions to provide participants with a comprehensive overview of the expertise, technologies and career opportunities that contribute to the dynamism of the Valais Life Sciences ecosystem.
As part of the programme, RegenLab opened its doors to participants, offering a unique opportunity to discover the infrastructure, processes and expertise that support the development and manufacture of regenerative medicine solutions.
A behind-the-scenes look at regenerative medicine manufacturing
Represented by Fabrice Vulliens, Production Director, RegenLab guided visitors through its production and laboratory facilities located within BioArk Tech Park. Participants gained valuable insight into the rigorous standards and multidisciplinary expertise required to develop and manufacture regulated medical devices intended for regenerative applications.
A key focus of the visit was CellularMatrix, RegenLab’s ready-to-use autologous blood-derived matrix designed to support regenerative therapies. Through presentations and facility tours, attendees explored the different stages involved in production batch validation, quality control procedures and manufacturing operations conducted in controlled environments.
The visit highlighted the critical role of quality assurance, process validation and regulatory compliance in ensuring the safety, consistency and performance of advanced regenerative medicine solutions.
Inspiring the next generation of life sciences professionals
Beyond showcasing technologies and facilities, the event demonstrated the growing importance of collaboration between educational institutions and innovative healthcare companies.
As healthcare and Life Sciences continue to evolve, there is increasing demand for professionals combining scientific, technical and digital competencies. By providing direct exposure to real-world industrial environments, initiatives such as the OSP and SHE Discovery Day help bridge the gap between education and industry while fostering a deeper understanding of the diverse career paths available within the sector.
For participants, the opportunity to engage with experts from companies, universities and training institutions provided valuable perspective on the skills, knowledge and interdisciplinary collaboration that drive innovation in healthcare today.
RegenPRP™ - HA / Cellular Matrix
Closed-circuit preparation of a cell-friendly PRP-HA network; HA presented by Regen Lab as supporting matrix logic and hydration.
RegenPRP™ - HA / Cellular Matrix
Device used to prepare a combination of hyaluronic acid (HA) and platelet-rich plasma (PRP) for intra-articular injections for symptomatic treatment of pain and mobility improvement in knee osteoarthritis.
Driving innovation through collaboration
Founded in 2003, RegenLab has built an international reputation through its commitment to innovation, quality and the development of regenerative medicine solutions used worldwide. The company remains dedicated to advancing scientific and industrial excellence while contributing to the growth of the Life Sciences ecosystem in Valais.
RegenLab would like to thank BioArk Tech Park, OSP, SHE and all participants for their engagement and insightful discussions throughout the afternoon. Strengthening connections between education, research and industry remains essential to fostering the next generation of healthcare innovators and supporting continued progress in regenerative medicine.